US Stock MarketDetailed Quotes

Sunshine Biopharma (SBFM)

Watchlist
  • 2.370
  • +0.230+10.75%
Close Jun 11 16:00 ET
  • 2.390
  • +0.020+0.84%
Post 18:07 ET
5.03MMarket Cap-0.19P/E (TTM)

Sunshine Biopharma (SBFM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.25%-2.07M
57.44%-5.33M
52.54%-1.62M
46.35%-727.8K
71.77%-1.29M
46.78%-1.7M
-42.73%-12.52M
-26.60%-3.41M
-196.66%-1.36M
-21.17%-4.58M
Net income from continuing operations
-5.43%-1.24M
-16.39%-5.98M
0.80%-2.14M
26.21%-883.82K
-258.25%-1.77M
8.10%-1.18M
-13.94%-5.13M
-72.65%-2.16M
-83.86%-1.2M
45.21%-494.3K
Operating gains losses
----
--10.26K
----
----
----
----
----
----
----
----
Depreciation and amortization
18.62%76.86K
48.56%332.07K
50.74%98.58K
48.78%96.16K
42.57%72.53K
52.03%64.79K
49.87%223.53K
54.41%65.4K
73.75%64.63K
45.84%50.88K
Deferred tax
----
----
----
----
----
----
--0
----
----
----
Other non cash items
----
----
----
----
----
----
---2.24M
--291.42K
--4.38K
---2.55M
Change In working capital
-56.04%-905.09K
73.09%-1.45M
118.80%301.57K
-124.80%-512.07K
58.67%-655.77K
70.35%-580.02K
-21.64%-5.37M
-8.20%-1.6M
75.42%-227.79K
13.15%-1.59M
-Change in receivables
-242.87%-609.6K
95.03%-116.17K
104.06%41.29K
-165.84%-649.85K
103.71%65.71K
179.56%426.67K
-293.54%-2.34M
-113.81%-1.02M
1,658.68%986.99K
-827.45%-1.77M
-Change in inventory
113.78%78.4K
72.74%-1.64M
142.82%772.8K
-2.66%-1.29M
34.61%-555.08K
72.92%-568.83K
-153.93%-6.01M
-57.71%-1.8M
-273.01%-1.25M
-81.41%-848.85K
-Change in prepaid assets
19.45%82.99K
332.08%480.8K
141.23%189.08K
-56.81%36.17K
-74.74%186.07K
112.21%69.47K
-879.84%-207.17K
-70.39%-458.56K
28.58%83.74K
1,289.80%736.64K
-Change in payables and accrued expense
13.40%-455.66K
-105.99%-189.96K
-142.98%-717.91K
3,137.98%1.39M
-212.12%-333.65K
-142.11%-526.17K
320.66%3.17M
310.54%1.67M
92.29%-45.68K
124.38%297.58K
-Change in other current assets
46.66%52.79K
159.68%203.84K
----
----
----
--35.99K
---341.53K
----
----
----
-Change in other current liabilities
-214.69%-54K
-153.90%-187.52K
----
----
----
---17.16K
--347.94K
----
----
----
Cash from discontinued investing activities
Operating cash flow
-22.25%-2.07M
57.44%-5.33M
52.54%-1.62M
46.35%-727.8K
71.77%-1.29M
46.78%-1.7M
-42.73%-12.52M
-26.60%-3.41M
-196.66%-1.36M
-21.17%-4.58M
Investing cash flow
Cash flow from continuing investing activities
50.70%-104.52K
57.75%-836.31K
48.65%-50.21K
82.36%-118.3K
15.94%-455.79K
68.30%-212.02K
-201.66%-1.98M
63.69%-97.77K
-3,655.86%-670.6K
-108.96%-542.21K
Net PPE purchase and sale
31.52%-5.13K
89.47%-174.49K
91.02%-9.21K
84.05%-92.19K
93.05%-65.6K
76.50%-7.49K
-3,434.25%-1.66M
-124.62%-102.6K
-2,850.40%-578.08K
-124.16%-944.5K
Net intangibles purchase and sale
51.41%-99.39K
-105.37%-661.82K
-948.82%-41K
71.79%-26.1K
-196.99%-390.19K
67.89%-204.53K
54.34%-322.26K
100.70%4.83K
-4,185.27%-92.52K
150.26%402.3K
Cash from discontinued investing activities
Investing cash flow
50.70%-104.52K
57.75%-836.31K
48.65%-50.21K
82.36%-118.3K
15.94%-455.79K
68.30%-212.02K
-201.66%-1.98M
63.69%-97.77K
-3,655.86%-670.6K
-108.96%-542.21K
Financing cash flow
Cash flow from continuing financing activities
0
-46.90%4.75M
-55.23%724.5K
-96.13%75.54K
12,670.67%3.59M
-93.42%355.3K
161.02%8.94M
5,402.28%1.62M
3,173.66%1.95M
-100.70%-28.58K
Net issuance payments of debt
----
----
----
----
-104.23%-58.38K
42.05%-17.16K
376.16%347.94K
1,425.99%435.79K
-1.38%-29.66K
11.76%-28.58K
Net common stock issuance
----
-66.03%1.83M
--0
--0
--1.83M
--0
51.71%5.38M
--0
--0
--0
Proceeds from stock option exercised by employees
--0
-17.96%2.92M
-55.23%724.5K
--0
--1.84M
689.55%355.3K
101,522.27%3.56M
68,877.07%1.62M
--1.9M
--0
Cash from discontinued financing activities
Financing cash flow
--0
-46.90%4.75M
-55.23%724.5K
-96.13%75.54K
12,670.67%3.59M
-93.42%355.3K
161.02%8.94M
5,402.28%1.62M
3,173.66%1.95M
-100.70%-28.58K
Net cash flow
Beginning cash position
-5.81%9.12M
-40.55%9.69M
-23.76%9.31M
-10.45%10.31M
-53.40%8.12M
-40.55%9.69M
-25.35%16.29M
-35.23%12.21M
-41.67%11.51M
-9.64%17.43M
Current changes in cash
-40.27%-2.18M
74.49%-1.42M
50.04%-941.72K
-950.21%-770.56K
135.84%1.85M
-200.48%-1.55M
7.38%-5.56M
36.95%-1.88M
85.38%-73.37K
-25,270.25%-5.15M
Effect of exchange rate changes
-230.26%-33.68K
182.02%855.75K
219.41%758.59K
-129.56%-228.32K
143.15%335.68K
97.47%-10.2K
-321.23%-1.04M
-245.83%-635.3K
302.51%772.28K
-287.53%-777.89K
End cash Position
-14.91%6.91M
-5.81%9.12M
-5.81%9.12M
-23.76%9.31M
-10.45%10.31M
-53.40%8.12M
-40.55%9.69M
-40.55%9.69M
-35.23%12.21M
-41.67%11.51M
Free cash flow
-14.14%-2.18M
57.48%-6.17M
52.73%-1.66M
61.25%-761.94K
64.22%-1.84M
50.91%-1.91M
-51.67%-14.5M
-17.03%-3.5M
-319.14%-1.97M
-26.47%-5.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.25%-2.07M57.44%-5.33M52.54%-1.62M46.35%-727.8K71.77%-1.29M46.78%-1.7M-42.73%-12.52M-26.60%-3.41M-196.66%-1.36M-21.17%-4.58M
Net income from continuing operations -5.43%-1.24M-16.39%-5.98M0.80%-2.14M26.21%-883.82K-258.25%-1.77M8.10%-1.18M-13.94%-5.13M-72.65%-2.16M-83.86%-1.2M45.21%-494.3K
Operating gains losses ------10.26K--------------------------------
Depreciation and amortization 18.62%76.86K48.56%332.07K50.74%98.58K48.78%96.16K42.57%72.53K52.03%64.79K49.87%223.53K54.41%65.4K73.75%64.63K45.84%50.88K
Deferred tax --------------------------0------------
Other non cash items ---------------------------2.24M--291.42K--4.38K---2.55M
Change In working capital -56.04%-905.09K73.09%-1.45M118.80%301.57K-124.80%-512.07K58.67%-655.77K70.35%-580.02K-21.64%-5.37M-8.20%-1.6M75.42%-227.79K13.15%-1.59M
-Change in receivables -242.87%-609.6K95.03%-116.17K104.06%41.29K-165.84%-649.85K103.71%65.71K179.56%426.67K-293.54%-2.34M-113.81%-1.02M1,658.68%986.99K-827.45%-1.77M
-Change in inventory 113.78%78.4K72.74%-1.64M142.82%772.8K-2.66%-1.29M34.61%-555.08K72.92%-568.83K-153.93%-6.01M-57.71%-1.8M-273.01%-1.25M-81.41%-848.85K
-Change in prepaid assets 19.45%82.99K332.08%480.8K141.23%189.08K-56.81%36.17K-74.74%186.07K112.21%69.47K-879.84%-207.17K-70.39%-458.56K28.58%83.74K1,289.80%736.64K
-Change in payables and accrued expense 13.40%-455.66K-105.99%-189.96K-142.98%-717.91K3,137.98%1.39M-212.12%-333.65K-142.11%-526.17K320.66%3.17M310.54%1.67M92.29%-45.68K124.38%297.58K
-Change in other current assets 46.66%52.79K159.68%203.84K--------------35.99K---341.53K------------
-Change in other current liabilities -214.69%-54K-153.90%-187.52K---------------17.16K--347.94K------------
Cash from discontinued investing activities
Operating cash flow -22.25%-2.07M57.44%-5.33M52.54%-1.62M46.35%-727.8K71.77%-1.29M46.78%-1.7M-42.73%-12.52M-26.60%-3.41M-196.66%-1.36M-21.17%-4.58M
Investing cash flow
Cash flow from continuing investing activities 50.70%-104.52K57.75%-836.31K48.65%-50.21K82.36%-118.3K15.94%-455.79K68.30%-212.02K-201.66%-1.98M63.69%-97.77K-3,655.86%-670.6K-108.96%-542.21K
Net PPE purchase and sale 31.52%-5.13K89.47%-174.49K91.02%-9.21K84.05%-92.19K93.05%-65.6K76.50%-7.49K-3,434.25%-1.66M-124.62%-102.6K-2,850.40%-578.08K-124.16%-944.5K
Net intangibles purchase and sale 51.41%-99.39K-105.37%-661.82K-948.82%-41K71.79%-26.1K-196.99%-390.19K67.89%-204.53K54.34%-322.26K100.70%4.83K-4,185.27%-92.52K150.26%402.3K
Cash from discontinued investing activities
Investing cash flow 50.70%-104.52K57.75%-836.31K48.65%-50.21K82.36%-118.3K15.94%-455.79K68.30%-212.02K-201.66%-1.98M63.69%-97.77K-3,655.86%-670.6K-108.96%-542.21K
Financing cash flow
Cash flow from continuing financing activities 0-46.90%4.75M-55.23%724.5K-96.13%75.54K12,670.67%3.59M-93.42%355.3K161.02%8.94M5,402.28%1.62M3,173.66%1.95M-100.70%-28.58K
Net issuance payments of debt -----------------104.23%-58.38K42.05%-17.16K376.16%347.94K1,425.99%435.79K-1.38%-29.66K11.76%-28.58K
Net common stock issuance -----66.03%1.83M--0--0--1.83M--051.71%5.38M--0--0--0
Proceeds from stock option exercised by employees --0-17.96%2.92M-55.23%724.5K--0--1.84M689.55%355.3K101,522.27%3.56M68,877.07%1.62M--1.9M--0
Cash from discontinued financing activities
Financing cash flow --0-46.90%4.75M-55.23%724.5K-96.13%75.54K12,670.67%3.59M-93.42%355.3K161.02%8.94M5,402.28%1.62M3,173.66%1.95M-100.70%-28.58K
Net cash flow
Beginning cash position -5.81%9.12M-40.55%9.69M-23.76%9.31M-10.45%10.31M-53.40%8.12M-40.55%9.69M-25.35%16.29M-35.23%12.21M-41.67%11.51M-9.64%17.43M
Current changes in cash -40.27%-2.18M74.49%-1.42M50.04%-941.72K-950.21%-770.56K135.84%1.85M-200.48%-1.55M7.38%-5.56M36.95%-1.88M85.38%-73.37K-25,270.25%-5.15M
Effect of exchange rate changes -230.26%-33.68K182.02%855.75K219.41%758.59K-129.56%-228.32K143.15%335.68K97.47%-10.2K-321.23%-1.04M-245.83%-635.3K302.51%772.28K-287.53%-777.89K
End cash Position -14.91%6.91M-5.81%9.12M-5.81%9.12M-23.76%9.31M-10.45%10.31M-53.40%8.12M-40.55%9.69M-40.55%9.69M-35.23%12.21M-41.67%11.51M
Free cash flow -14.14%-2.18M57.48%-6.17M52.73%-1.66M61.25%-761.94K64.22%-1.84M50.91%-1.91M-51.67%-14.5M-17.03%-3.5M-319.14%-1.97M-26.47%-5.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th, Eastern Time, Trump stated he would launch a military strike against Iran that evening, directly targeting key o Show More